Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Scientific Reports|October 7, 2022
CDK4/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1/S transitionSungsoo Kim, Alessandra Leong, Minah Kim, et al.
Nature Communications|July 21, 2025
E2F activity determines mitosis versus whole-genome duplication in G2-arrested cellsKibum Kim, Jessica Armand, Sungsoo Kim, et al.
Cell Reports|May 30, 2023
Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanomaSungsoo Kim, Richard Carvajal, Minah Kim, et al.
The Journal of Clinical Investigation|August 12, 2025
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer modelsSungsoo Kim, Eugene Son, Ha-Ram Park, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancerJessica Armand, Sungsoo Kim, Kibum Kim, et al.
Cell Reports|October 22, 2023
Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancerSungsoo Kim, Jessica Armand, Anton Safonov, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 23, 2024
Investigating Heterogeneous Cell-Cycle Progression Using Single-Cell Imaging ApproachesHee Won Yang
Journal of Gastric Cancer|January 6, 2017
Outcome of Gastric Cancer Surgery in Elderly PatientsMin Sung Kim, Sungsoo Kim
Pageof 21